Reflections on the NatureCHI workshop series: unobtrusive user experiences with technology in nature

J Häkkilä, NJ Bidwell, K Cheverst, A Colley… - International Journal of …, 2018 - igi-global.com
Being in nature is often regarded to be calming, relaxing and purifying. While technology
has the potential to support engagement with nature, develo** systems that provide …

Navigating the graveyard: designing technology for deathscapes

J Häkkilä, MT Forsman, A Colley - Proceedings of the 17th International …, 2018 - dl.acm.org
In this paper, we consider graveyards as a design context, and present a prototype
graveyard-navigator mobile application. The app enables search and navigation to …

Reconnecting An International Travel Network: The Personal Infrastructuring Work of International Travelers in A Multi-facet Crisis

Y Lyu, H Zhang, J Carroll - … of the Eleventh International Symposium of …, 2023 - dl.acm.org
In times of crisis, international travel becomes tenuous and anxiety provoking. The crisis
informatics and Human-Computer Interaction (HCI) community has paid increasing attention …

[PDF][PDF] Volunteer's demographics and motivations in senseBox and openSenseMap

M Pesch, T Bartoschek - Forum Citiz Sci, 2019 - researchgate.net
This study examines the openSenseMap, an Open Data web platform for storing and
analyzing sensor data. The openSenseMap consists of over 4000 sensor stations, is used …

[PDF][PDF] Reflections on the NatureCHI Workshop Series: Unobtrusive User Experiences

J Häkkilä, A Colley, J Schöning - Reflections, 2018 - core.ac.uk
Being in nature is often regarded to be calming, relaxing and purifying. While technology
has the potential to support engagement with nature, develo** systems that provide …

Estudo imunofenotípico dos linfócitos T TCRαβ+ CD3+ CD4-CD8-para diagnóstico de síndrome linfoproliferativa autoimune

FSF Coutinho - 2021 - search.proquest.com
Introdução e Objetivos: A Síndrome Linfoproliferativa Autoimune (ALPS) é uma patologia
rara ligada a defeitos na apoptose pela via do FAS. Consiste em “linfoproliferação” crónica …